0% found this document useful (0 votes)
13 views15 pages

Tetanus

Tetanus is caused by Clostridium tetani, which produces toxins leading to muscle spasms and autonomic dysfunction. The disease can manifest in various forms, including generalized, neonatal, localized, and cephalic tetanus, with severe cases having high mortality rates. Prevention through vaccination is crucial, and treatment involves immunoglobulin administration, wound care, and management of symptoms.

Uploaded by

allhoahmed55
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
13 views15 pages

Tetanus

Tetanus is caused by Clostridium tetani, which produces toxins leading to muscle spasms and autonomic dysfunction. The disease can manifest in various forms, including generalized, neonatal, localized, and cephalic tetanus, with severe cases having high mortality rates. Prevention through vaccination is crucial, and treatment involves immunoglobulin administration, wound care, and management of symptoms.

Uploaded by

allhoahmed55
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

TETANUS

GILL G.V., BEECHING N.J. TROPICAL MEDICINE, 5 TH EDITION.


BACTERIOLOGY & PATHOGENESIS:
♦. Tetanus is caused by Clostridium tetani, a Gram- positive obligate
anaerobe spore forming bacteria.
♦. Spores are particularly found in soil and are highly resistant to light and
temperature; clinical disease occurs when spores are inoculated into wounds.
♦. Spores germinate under anaerobic conditions at the site of the wound and
the growing bacteria produce two toxin: tetanolysin and tetanospasmin.
BACTERIOLOGY & PATHOGENESIS:
♦. Tetanospasmin enters the presynaptic nerve terminal and prevents
transmitter release.
♦. Tetanospasmin is able to travel retrogradely via axon to cell bodies and
cross synapses, thus reaching the spinal cord, brain and autonomic
nervous system.
♦. It primarily affects glycine and GABA neurones leading to increase firing
and of normal relaxation and causing the classical spasms of tetanus.
CLINICAL MANIFESTATIONS:

♦. The incubation period varies according to the site of


injury and is shorter in severe disease, with average
incubation of 8 days for severe disease.
♦. There are several classical clinical sub-types, which
reflect the main site of action of toxin
GENERALIZED TETANUS:

♦. Generalized tetanus often commences with trismus (lock


jaw) in which the patient is unable to open his mouth or
risus sardonicus, a grimace caused by spasm patient facial
muscle.
♦. The predominant feature is of repeated spasms which
may involve the neck, thorax, abdomen or extremities.
♦. Generalized spasm with opisthotonos also occur.
GENERALIZED TETANUS:

♦. Spasms are painful and full consciousness is retained.


♦. Respiratory compromise may occur due to involvement of
the glottis or diaphragm.
♦. The disease may continue to progress for up to 10 days
after the first symptoms.
♦. In severe tetanus, autonomic dysfunction may occur after
several days.
GENERALIZED TETANUS:

♦. Hypertension, tachycardia, arrhythmias, hyperpyrexia my


all occur and can be extremely difficult to manage.
♦. Recovery may take up to 4 weeks.
♦. Case fatality rates can reach 60%, with death usually
occurring because respiratory or autonomic involvement.
NEONATAL TETANUS:
♦. This is usually caused by infection of the umbilical stump.
♦. The risk of infection is related to the cleanliness of the
environment.
♦. Neonatal tetanus only occurs in the children of non-immune
mothers.
♦. Symptoms and signs occur 1-10 days postpartum .
♦. Initially, generalized weakness and floppiness of the baby are
noticed, with irritability and an inability to suck and feed.
NEONATAL TETANUS:

♦. Subsequently, spasms, opisthotonos and


hypersympathetic states occur.
♦. Up to 90% of affected infants die and mental retardation
is common in survivors.
LOCALIZED TETANUS:
♦. This usually a mild form in which rigidity is limited to muscles near
the site of injury.
♦. Weakness may of the muscles may also occur because of the
action of the toxin at the neuromuscular junction.
♦. Symptoms may mild and persist for months.
♦. If the diagnosis is not made, progression to the generalized form
may occur.
CEPHALIC TETANUS:

♦. This the rarest form and occur in head injuries or with


middle ear infection.
♦. The incubation period is normally 1-2 days.
♦. The major clinical manifestations are caused by
involvement of cranial nerves with facial paresis, dysphagia
and extraocular palsies.
♦. This form can also progress to generalized tetanus.
DIAGNOSIS:

♦. The diagnosis is usually made clinically.


♦. Blood and CSF findings are usually normal.
♦. The differential diagnosis is limited but includes:
strychnine poisoning, dystonic reactions, hypocalcaemia
and seizures in adults and metabolic or neurological
causes of posturing in neonates.
TREATMENT:

♦. Tetanus should be treated by the administration of


tetanus immunoglobulin (human tetanus Ig5 500-5000 IU
i.m. or equine tetanus IG IU i.m.).
♦. Wound should be debrided to prevent further germination
of spores.
♦. Metronidazole or benzylpenicillin should be given to
prevent the multiplication of bacteria.
TREATMENT:
♦. External stimulation should be reduced to prevent precipitation of spasms: patients
should be nursed a quiet, dim room.
♦. The airway should be protected; endotracheal intubation or tracheostomy is
sometimes necessary.
♦. Spasm can be treated by the use of high doses of benzodiazepines; baclofen is
also effective.
♦. Some patients require paralysis with neuromuscular junction blockers.
♦. Intravenous labetalol is useful for the management of hypertension; atropine or
pacing may be needed for bradycardias and sympathomimetics and fluids are
sometimes necessary to treat hypotension.
EPIDEMIOLOGY & PREVENTION:
There has been a significant reduction in the number of cases through the use of
vaccination, particularly maternal vaccination and better obstetric practice.
Tetanus is a vaccine-preventable disease. Immunization with tetanus toxoid is very effective.
A single dose of tetanus toxoid in pregnancy leads to protectives titers in mother and
neonate. Non-immunized mothers should received two doses during pregnancy.
Routine booster doses should be given at 10 yearly intervals, or for tetanus –prone injuries if
not immunized within the last 5 years.
There is no need to give more than five doses in a lifetime.
Gill G.V., Beeching N.J. Tropical Medicine, 5 th edition.

You might also like